Literature DB >> 22341733

Epidemiology, pathology, immunology and diagnosis of bovine farcy: a review.

Mohamed E Hamid1.   

Abstract

Bovine farcy (which is caused by Mycobacterium farcinogenes and Mycobacterium senegalense) is a chronic suppurative granulomatous inflammation of the skin and lymphatics of cattle and is seen mostly in sub-Saharan Africa. It is not yet certain whether Nocardia farcinica causes cutaneous nocardiosis (farcy) in animals that mimics bovine farcy. Epidemiological data have steadily reported finding bovine farcy in adult cattle of the transhumance pastoralist tribes of the Sahel and the Sudanian savannah zones. M. farcinogenes and or M. senegalense do not affect other domestic or non-domestic animals; it is not known whether these bacteria are zoonotic. The disease--once widespread in many regions--has disappeared from some countries historically known to have it. Reports of bovine farcy prevalence seem to be linked to the existence of survey initiatives by governments and diagnostic capabilities in each country. Farcy causes economic loss due to damaged hides and also is a public-health burden (because the lymphadenitis due to farcy resembles the lesions of bovine tuberculosis in carcasses and the meat is considered inappropriate for human consumption). The current literature is deficient in establishing definitely the prevalence, transmission patterns, and risk factors of bovine farcy. Ixodid ticks transmit other skin diseases (such as dermatophilosis) and might play a role in bovine farcy (given the similarity in the bio-physiology and geographic distribution of the disease). In addition, the tick-resistance of cattle breeds such as the N'Dama, Fulani or the Nilotic might explain their resistance to bovine farcy. Apart from the judicious use of conventional smear-and-culture methods, few diagnostic tests have been developed; the molecular and serological tests have not been evaluated for reproducibility and accuracy. This review points out aspects of bovine farcy that need further research and updates available data on the prevalence, distribution, risk factors, economic and public health implications, diagnosis, and control.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22341733     DOI: 10.1016/j.prevetmed.2012.01.004

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  6 in total

1.  Bovine tuberculosis in South Darfur State, Sudan: an abattoir study based on microscopy and molecular detection methods.

Authors:  El Tigani A Asil; Sulieman M El Sanousi; Ahmed Gameel; Haytham El Beir; Maha Fathelrahman; Nasir M Terab; Magzoub A Muaz; Mohamed E Hamid
Journal:  Trop Anim Health Prod       Date:  2012-07-29       Impact factor: 1.559

2.  Soil-acquired cutaneous nocardiosis on the forearm of a healthy male contracted in a swamp in rural eastern Virginia.

Authors:  James R Palmieri; Arben Santo; Shawn E Johnson
Journal:  Int Med Case Rep J       Date:  2014-03-07

3.  Nocardia cyriacigeogica from Bovine Mastitis Induced In vitro Apoptosis of Bovine Mammary Epithelial Cells via Activation of Mitochondrial-Caspase Pathway.

Authors:  Wei Chen; Yongxia Liu; Limei Zhang; Xiaolong Gu; Gang Liu; Muhammad Shahid; Jian Gao; Tariq Ali; Bo Han
Journal:  Front Cell Infect Microbiol       Date:  2017-05-18       Impact factor: 5.293

4.  Mycobacterium farcinogenes osteomyelitis of the proximal tibia: A case report.

Authors:  Fatma Al Farsi; Badriya Al Adawi; Hashim Ba Tahir; Mohammed Al Mutani; Chamila Adikaram; Turkiya Al Siyabi; Ibrahim Al Busaidi
Journal:  IDCases       Date:  2021-06-15

Review 5.  Current Perspectives on Mycobacterium farcinogenes and Mycobacterium senegalense, the Causal Agents of Bovine Farcy.

Authors:  Mohamed E Hamid
Journal:  Vet Med Int       Date:  2014-04-30

6.  Draft Genome Sequence of Mycobacterium farcinogenes NCTC 10955.

Authors:  Olivier Croce; Catherine Robert; Didier Raoult; Michel Drancourt
Journal:  Genome Announc       Date:  2014-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.